Andrew Burch - 31 Oct 2024 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
President, Nucleic Acid Production
Signature
/s/ Kurt Oreshack, by power of attorney for Andrew Burch
Issuer symbol
MRVI
Transactions as of
31 Oct 2024
Net transactions value
+$10,494
Form type
4
Filing time
12 Nov 2024, 16:59:29 UTC
Previous filing
02 May 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $10,494 +1,841 +0.44% $5.70 423,595 31 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,841 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

President, Nucleic Acid Production